Burlington, Ontario — February 11, 2026 — Leads & Copy —
Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF), a Canadian biotechnology company, has announced its common shares are now trading in the United States on the OTCQB Venture Market under the ticker symbol RDTCF.
The OTCQB listing is expected to expand Rapid Dose Therapeutics’ presence in the U.S. capital markets by increasing accessibility and visibility for American investors.
According to the company, the OTCQB will provide direct access to the company’s shares, enhancing liquidity, broadening market participation, and strengthening engagement with the North American life sciences investment community.
CEO of Rapid Dose Therapeutics, Mark Upsdell, said that trading on the OTCQB strengthens the company’s visibility with U.S. investors and aligns with its long-term strategy to support growth, partnerships, and commercialization across multiple verticals.
Upsdell added that, with growing demand for innovative drug delivery systems and the company’s expanding QuickStrip™ oral thin film portfolio, this milestone positions Rapid Dose Therapeutics for accelerated growth and long-term shareholder value.
Rapid Dose Therapeutics’ flagship product, QuickStrip™, is a rapidly dissolving oral thin film that delivers a controlled dose of active ingredients through sublingual or buccal absorption, offering a reliable, discreet, and easy-to-use method of administration.
The OTCQB Venture Market, operated by OTC Markets Group, is designed for growth-stage and emerging companies that maintain transparent financial reporting and meet ongoing compliance standards, providing investors with greater confidence and market integrity.
Rapid Dose Therapeutics will continue trading in Canada on the Canadian Securities Exchange (CSE) under the symbol DOSE.
For more information on Rapid Dose Therapeutics on the OTCQB, visit: https://www.otcmarkets.com/stock/RDTCF/profile
Rapid Dose Therapeutics is a Canadian biotechnology company revolutionizing drug delivery through innovation. The Company’s flagship product QuickStrip™ is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient.
Source: Rapid Dose Therapeutics Corp.
